Virtual Reality Intervention for Fear of Heights

July 22, 2024 updated by: Boston University Charles River Campus

The Influence of Music on Response to Virtual Reality-Based Exposure for Acrophobia

Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.

Study Overview

Detailed Description

The goal of this clinical trial is to compare acrophobia (fear of heights) outcomes for VR exposure therapy in college students with elevated acrophobia when listening to music during exposure versus no music. The overarching aim of the current study is to determine how liked, non-lyrical background music will influence acrophobia outcomes after a brief exposure therapy session in VR.

The study involves three phases: (1) initial screening, (2) in-person assessment and a brief exposure intervention for a subset of participants with elevated acrophobia, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on an acrophobia scale will be assigned to an experimental or control condition prior to undergoing VR based exposure therapy. Acrophobia outcomes are measured immediately post-intervention and one week later.

Researchers will compare participants in the music condition to participants in the non-music condition to see if acrophobia outcomes differ.

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Michael Otto, PhD
  • Phone Number: 617-353-9610
  • Email: mwotto@bu.edu

Study Contact Backup

  • Name: Laura J Long, PhD
  • Phone Number: 617-358-4303
  • Email: ljlong@bu.edu

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Recruiting
        • Boston University
        • Principal Investigator:
          • Michael W. Otto, Ph.D.
        • Contact:
          • Laura J. Long, Ph.D.
          • Phone Number: 617-358-4303
          • Email: ljlong@bu.edu
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-report of 18 years of age or older
  • Current student at Boston University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet)
  • For Phase 2: Acrophobia score of ≥ 45.45 on the Acrophobia Questionnaire (AQ) Anxiety Subscale

Exclusion Criteria:

  • Previous participation (i.e. no participant may take the survey more than once).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exposure Intervention with Non-Lyrical, Liked Background Music
Participants will be presented with a list of instrumental songs without lyrics from popular movies. Participants will then rank the songs in order of those they would like to hear the most. During VR heights exposure the participants' highest-ranked songs will be played in the background at a low volume.
VR exposure for acrophobia with background music.
Experimental: Exposure Intervention without Background Music
Participants will undergo VR heights exposure without background music.
VR exposure for acrophobia with no background music.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acrophobia (Fear of Heights)
Time Frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Assessed using the Acrophobia Questionnaire (AQ) Anxiety Subscale
Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Valance
Time Frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Self-report measure of how participant feels about experiencing high-height environments.
Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Height-Relevant Interpretations
Time Frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Assessed using the Heights Interpretation Questionnaire (HIQ)
Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Long, PhD, Boston University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

June 16, 2024

First Submitted That Met QC Criteria

June 16, 2024

First Posted (Actual)

June 21, 2024

Study Record Updates

Last Update Posted (Actual)

July 23, 2024

Last Update Submitted That Met QC Criteria

July 22, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 7169E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acrophobia

Clinical Trials on Exposure Intervention Plus Music Induction

Subscribe